Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/jcm9113572
- Scopus: eid_2-s2.0-85113650560
- PMID: 33171906
- WOS: WOS:000593286200001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Lycium barbarum Polysaccharide Suppresses Expression of Fibrotic Proteins in Primary Human Corneal Fibroblasts
Title | Lycium barbarum Polysaccharide Suppresses Expression of Fibrotic Proteins in Primary Human Corneal Fibroblasts |
---|---|
Authors | |
Keywords | Lycium barbarum polysaccharides corneal scarring human keratocytes fibroblast TGFβ1 |
Issue Date | 2020 |
Publisher | MDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/jcm |
Citation | Journal of Clinical Medicine, 2020, v. 9 n. 11, p. article no. 3572 How to Cite? |
Abstract | (1) Objective: To study the anti-fibrotic effects of Lycium barbarum polysaccharides (LBP) on corneal stromal fibroblasts and assess LBP’s effect on cell viability. (2) Methods: Primary human corneal keratocytes of passage 3 to 6 were used for all experiments. Cells are pretreated with LBP solution for 24 h and then transforming growth factor beta 1 (TGFβ1) for 48 h and collected for experiments. Fibrotic protein analysis was performed using immunofluorescence and Western blot. The effect of LBP on cell viability was assessed using the MTS assay. (3) Results: LBP significantly reduced the expression of fibrotic proteins, including α-SMA and extracellular matrix proteins (collagen type I and III). LBP significantly decreased the viability of myofibroblasts but not the fibroblasts. Conclusions: In this study, LBP was effective in the prevention of fibrosis gene expression. Further studies to assess the underlying mechanism and pharmacological properties will facilitate the formation of a topical LBP solution for in vivo studies. |
Persistent Identifier | http://hdl.handle.net/10722/293488 |
ISSN | 2021 Impact Factor: 4.964 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwok, SS | - |
dc.contributor.author | Wong, SY | - |
dc.contributor.author | Shih, KC | - |
dc.contributor.author | Chan, YK | - |
dc.contributor.author | BU, Y | - |
dc.contributor.author | Chan, TCY | - |
dc.contributor.author | Ng, ALK | - |
dc.contributor.author | Lo, ACY | - |
dc.contributor.author | Tong, L | - |
dc.contributor.author | Yam, GHF | - |
dc.contributor.author | Jhanji, V | - |
dc.date.accessioned | 2020-11-23T08:17:30Z | - |
dc.date.available | 2020-11-23T08:17:30Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Journal of Clinical Medicine, 2020, v. 9 n. 11, p. article no. 3572 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | http://hdl.handle.net/10722/293488 | - |
dc.description.abstract | (1) Objective: To study the anti-fibrotic effects of Lycium barbarum polysaccharides (LBP) on corneal stromal fibroblasts and assess LBP’s effect on cell viability. (2) Methods: Primary human corneal keratocytes of passage 3 to 6 were used for all experiments. Cells are pretreated with LBP solution for 24 h and then transforming growth factor beta 1 (TGFβ1) for 48 h and collected for experiments. Fibrotic protein analysis was performed using immunofluorescence and Western blot. The effect of LBP on cell viability was assessed using the MTS assay. (3) Results: LBP significantly reduced the expression of fibrotic proteins, including α-SMA and extracellular matrix proteins (collagen type I and III). LBP significantly decreased the viability of myofibroblasts but not the fibroblasts. Conclusions: In this study, LBP was effective in the prevention of fibrosis gene expression. Further studies to assess the underlying mechanism and pharmacological properties will facilitate the formation of a topical LBP solution for in vivo studies. | - |
dc.language | eng | - |
dc.publisher | MDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/jcm | - |
dc.relation.ispartof | Journal of Clinical Medicine | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Lycium barbarum polysaccharides | - |
dc.subject | corneal scarring | - |
dc.subject | human keratocytes | - |
dc.subject | fibroblast | - |
dc.subject | TGFβ1 | - |
dc.title | Lycium barbarum Polysaccharide Suppresses Expression of Fibrotic Proteins in Primary Human Corneal Fibroblasts | - |
dc.type | Article | - |
dc.identifier.email | Shih, KC: kcshih@hku.hk | - |
dc.identifier.email | Chan, YK: josephyk@connect.hku.hk | - |
dc.identifier.email | Lo, ACY: amylo@hku.hk | - |
dc.identifier.authority | Shih, KC=rp01374 | - |
dc.identifier.authority | Chan, YK=rp02536 | - |
dc.identifier.authority | Ng, ALK=rp01842 | - |
dc.identifier.authority | Lo, ACY=rp00425 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3390/jcm9113572 | - |
dc.identifier.pmid | 33171906 | - |
dc.identifier.pmcid | PMC7694544 | - |
dc.identifier.scopus | eid_2-s2.0-85113650560 | - |
dc.identifier.hkuros | 319096 | - |
dc.identifier.volume | 9 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | article no. 3572 | - |
dc.identifier.epage | article no. 3572 | - |
dc.identifier.isi | WOS:000593286200001 | - |
dc.publisher.place | Switzerland | - |
dc.identifier.issnl | 2077-0383 | - |